Enliven Therapeutics ELVN
NASDAQ ELVN
$45.72 -0.79 (-1.71%)
As of: Sep 30, 2026 · 1:10 PM EDT

Enliven Therapeutics, Inc. (ELVN) Operating Leases (2021 - 2022)

Updated

Enliven Therapeutics (ELVN) recorded Operating Leases of $1.97 million in Q1 2022, up 233.4% from $590,000 a year earlier and up 384.5% from the prior quarter.

Analysis

Enliven Therapeutics, Inc. (ELVN) Operating Leases (2021 - 2022) Analysis & Trends

At the end of FY2021, Enliven Therapeutics reported Operating Leases of $406,000.

  • Per Business Quant, the preceding three quarters came in at $406,000 (Q4 2021), $466,000 (Q3 2021) and $528,000 (Q2 2021).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.97 Mn
Dec 31, 2021 406,000.00
Sep 30, 2021 466,000.00
Jun 30, 2021 528,000.00
Mar 31, 2021 590,000.00
API Access

Enliven Therapeutics, Inc. Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ELVN&period=max&api_key=YOUR_API_KEY